Development of mammary tumors by conditional expression of GLI1.
暂无分享,去创建一个
[1] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[2] Hua Li,et al. Reciprocal Intraepithelial Interactions Between TP63 and Hedgehog Signaling Regulate Quiescence and Activation of Progenitor Elaboration by Mammary Stem Cells , 2008, Stem cells.
[3] K. Horwitz,et al. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts , 2008, Proceedings of the National Academy of Sciences.
[4] H. Varmus,et al. Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras , 2008, Proceedings of the National Academy of Sciences.
[5] S. Merajver,et al. BRCA1 regulates human mammary stem/progenitor cell fate , 2008, Proceedings of the National Academy of Sciences.
[6] Stephen J. Elledge,et al. Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.
[7] L. Montanaro,et al. The basal‐like breast carcinoma phenotype is regulated by SLUG gene expression , 2008, The Journal of pathology.
[8] M. Kleman,et al. Targeted Expression of GLI1 in the Mammary Gland Disrupts Pregnancy-induced Maturation and Causes Lactation Failure* , 2007, Journal of Biological Chemistry.
[9] M. Lauth,et al. Non-Canonical Activation of GLI Transcription Factors: Implications for Targeted Anti-Cancer Therapy , 2007, Cell cycle.
[10] R. Weinberg,et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.
[11] Alicia Zhou,et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.
[12] T. Shimokawa,et al. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists , 2007, Proceedings of the National Academy of Sciences.
[13] S. Hilsenbeck,et al. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia , 2007, Development.
[14] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[15] H. Phillip Koeffler,et al. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer , 2007, Breast Cancer Research and Treatment.
[16] Lee L. Rubin,et al. Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.
[17] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[18] P. Cowin,et al. Gli3-mediated repression of Hedgehog targets is required for normal mammary development , 2006, Development.
[19] G. Dontu,et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.
[20] G. Page,et al. Hedgehog signaling and response to cyclopamine differs in epithelial and stromal cells in benign breast and breast cancer , 2006, Cancer biology & therapy.
[21] M. Kraus,et al. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation , 2006, Oncogene.
[22] Joel Greshock,et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.
[23] P. A. Pérez-Mancera,et al. Cancer development induced by graded expression of Snail in mice. , 2005, Human molecular genetics.
[24] Robert D Cardiff,et al. The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.
[25] A. Howell,et al. A putative human breast stem cell population is enriched for steroid receptor-positive cells. , 2005, Developmental biology.
[26] P. Lichter,et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.
[27] Robert B Boxer,et al. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. , 2004, Cancer cell.
[28] E. Crivellato,et al. Mast cell contribution to angiogenesis related to tumour progression , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[29] G. Hortobagyi,et al. Prognostic molecular markers in early breast cancer , 2004, Breast Cancer Research.
[30] H. Varmus,et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Cornelius,et al. Matrix metalloproteinases: pro- and anti-angiogenic activities. , 2000, The journal of investigative dermatology. Symposium proceedings.
[33] C. Sugnet,et al. Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. , 1999, Development.
[34] D. Roop,et al. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[35] C. Eaves,et al. Epithelial Progenitors in the Normal Human Mammary Gland , 2005, Journal of Mammary Gland Biology and Neoplasia.